Amalgamated Bank Decreases Position in Agilent Technologies, Inc. (NYSE:A)

Amalgamated Bank trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 7.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 72,348 shares of the medical research company's stock after selling 5,464 shares during the quarter. Amalgamated Bank's holdings in Agilent Technologies were worth $10,059,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Carmel Capital Partners LLC raised its stake in Agilent Technologies by 1.2% during the 4th quarter. Carmel Capital Partners LLC now owns 6,709 shares of the medical research company's stock worth $933,000 after acquiring an additional 78 shares during the period. Monumental Financial Group Inc. raised its position in shares of Agilent Technologies by 0.9% during the 4th quarter. Monumental Financial Group Inc. now owns 9,493 shares of the medical research company's stock valued at $1,320,000 after purchasing an additional 89 shares during the period. Kepos Capital LP lifted its stake in shares of Agilent Technologies by 3.5% during the 3rd quarter. Kepos Capital LP now owns 2,775 shares of the medical research company's stock valued at $310,000 after buying an additional 93 shares in the last quarter. Rosenberg Matthew Hamilton boosted its holdings in Agilent Technologies by 51.1% in the 4th quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company's stock worth $39,000 after buying an additional 96 shares during the period. Finally, Invesco LLC increased its stake in Agilent Technologies by 0.7% in the 3rd quarter. Invesco LLC now owns 15,471 shares of the medical research company's stock worth $1,730,000 after buying an additional 101 shares in the last quarter.

Insider Activity

In other news, CEO Michael R. Mcmullen sold 52,297 shares of the company's stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $150.00, for a total transaction of $7,844,550.00. Following the transaction, the chief executive officer now owns 253,909 shares of the company's stock, valued at $38,086,350. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, CEO Michael R. Mcmullen sold 52,297 shares of the company's stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $150.00, for a total transaction of $7,844,550.00. Following the transaction, the chief executive officer now owns 253,909 shares of the company's stock, valued at $38,086,350. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Philip Binns sold 2,827 shares of the stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $147.54, for a total value of $417,095.58. Following the completion of the transaction, the senior vice president now directly owns 9,997 shares in the company, valued at approximately $1,474,957.38. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 61,610 shares of company stock valued at $9,220,333.

Wall Street Analysts Forecast Growth

A has been the subject of a number of recent analyst reports. UBS Group upped their price objective on Agilent Technologies from $130.00 to $155.00 and gave the stock a "neutral" rating in a research note on Wednesday, February 28th. Evercore ISI upped their price objective on Agilent Technologies from $132.00 to $145.00 and gave the stock an "in-line" rating in a research note on Thursday, April 4th. Barclays upped their price objective on Agilent Technologies from $125.00 to $135.00 and gave the stock an "underweight" rating in a research note on Wednesday, April 10th. Oppenheimer upped their price objective on Agilent Technologies from $67.00 to $90.00 and gave the stock an "outperform" rating in a research note on Tuesday, March 26th. Finally, Stifel Nicolaus raised Agilent Technologies from a "hold" rating to a "buy" rating and upped their price objective for the stock from $145.00 to $163.00 in a research note on Friday, April 5th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $141.29.

Agilent Technologies Trading Up 1.4 %

A stock traded up $1.93 during midday trading on Friday, reaching $139.45. 1,097,922 shares of the company traded hands, compared to its average volume of 1,239,688. Agilent Technologies, Inc. has a 52-week low of $96.80 and a 52-week high of $151.58. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.04 and a current ratio of 2.68. The business has a 50 day moving average of $142.07 and a 200-day moving average of $131.50. The firm has a market capitalization of $40.87 billion, a price-to-earnings ratio of 33.20, a P/E/G ratio of 4.17 and a beta of 1.13.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The medical research company reported $1.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.22 by $0.07. Agilent Technologies had a return on equity of 27.09% and a net margin of 18.35%. The business had revenue of $1.66 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the business posted $1.37 earnings per share. The company's quarterly revenue was down 5.5% compared to the same quarter last year. As a group, sell-side analysts expect that Agilent Technologies, Inc. will post 5.5 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, April 24th. Stockholders of record on Tuesday, April 2nd were paid a dividend of $0.236 per share. The ex-dividend date was Monday, April 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.68%. Agilent Technologies's dividend payout ratio is 22.38%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.